Herold Advisors’s Sanofi SNY Stock Holding History

Herold Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-578	Closed	-$29.7K	–	594
2022 Q1	$29.7K	Buy	+578	New	+$29.8K	0.01%	450
2021 Q4	–	Sell	-578	Closed	-$27K	–	571
2021 Q3	$27K	Buy	+578	New	+$29.4K	0.01%	475

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Herold Advisors's SNY Position: Q2 2022 in Review

Herold Advisors sold out of Sanofi (SNY) in Q2 2022, closing a stake of 578 shares — an estimated $29.7K sold.

Herold Advisors first reported a position in SNY in Q3 2021 and held it in 2 quarters. The position peaked at $29.7K in Q1 2022. 656 funds tracked by Wall St. Rank hold SNY as of Q2 2022.

Herold Advisors reported no remaining Sanofi position as of Q2 2022 after selling out during the quarter.
Herold Advisors sold 578 Sanofi shares in Q2 2022, an estimated $29.7K.
Herold Advisors first reported a position in Sanofi in Q3 2021 and held it in 2 quarters.
Herold Advisors's Sanofi position peaked at $29.7K in Q1 2022.
656 funds tracked by Wall St. Rank held Sanofi as of Q2 2022.

Based on Herold Advisors's 13F filing for Q2 2022, filed 15 Jul 2022.